Samara E - Search Results

1

BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study.

Borthakur G, Ofran Y, Tallman MS, Foran J, Uy GL, DiPersio JF, Showel MM, Shimoni A, Nagler A, Rowe JM, Altman JK, Abraham M, Peled A, Shaw S, Bohana-Kashtan O, Sorani E, Pereg Y, Foley-Comer A, Oberkovitz G, Lustig TM, Glicko-Kabir I, Aharon A, Vainstein-Haras A, Kadosh SE, Samara E, Al-Rawi AN, Pemmaraju N, Bueso-Ramos C, Cortes JE, Andreeff M. Borthakur G, et al. Among authors: samara e. Cancer. 2021 Apr 15;127(8):1246-1259. doi: 10.1002/cncr.33338. Epub 2020 Dec 3. Cancer. 2021. PMID: 33270904 Free article. Clinical Trial.

2

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.

Ziemssen T, Tumani H, Sehr T, Thomas K, Paul F, Richter N, Samara E, Spiegelstein O, Sorani E, Bar-Ilan O, Mimrod D, Hayardeny L. Ziemssen T, et al. Among authors: samara e. J Neuroinflammation. 2017 Aug 31;14(1):172. doi: 10.1186/s12974-017-0945-z. J Neuroinflammation. 2017. PMID: 28859672 Free PMC article. Clinical Trial.

3

Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study.

Samara E, Winkle P, Pardo P, Henney HR 3rd, Way SL, Brown E, Lee A, Blight AR. Samara E, et al. J Clin Pharmacol. 2014 Jan;54(1):53-60. doi: 10.1002/jcph.189. Epub 2013 Oct 22. J Clin Pharmacol. 2014. PMID: 24150835 Free PMC article. Clinical Trial.

4

A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.

Spiegelstein O, Mimrod D, Rabinovich L, Eyal E, Sprenger C, Elgart A, Samara E, Morganroth J. Spiegelstein O, et al. Among authors: samara e. Clin Pharmacol Drug Dev. 2019 Jan;8(1):49-59. doi: 10.1002/cpdd.442. Epub 2018 May 22. Clin Pharmacol Drug Dev. 2019. PMID: 29786964 Clinical Trial.

5

Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment.

Bialer M, Hadad S, Golomb G, Barel S, Samara E, Abu Salach O, Berkman N, Danenberg HD, Ben David J, Caron D, et al. Bialer M, et al. Among authors: samara e. Biopharm Drug Dispos. 1994 Jan;15(1):45-52. doi: 10.1002/bdd.2510150104. Biopharm Drug Dispos. 1994. PMID: 8161715 Clinical Trial.

6

Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.

Cascino GD, Tarquinio D, Wheless JW, Hogan RE, Sperling MR, Desai J, Vazquez B, Samara E, Misra SN, Carrazana E, Rabinowicz AL; DIAZ.001.05 Study Group. Cascino GD, et al. Among authors: samara e. Epilepsia. 2022 Jul;63(7):1714-1723. doi: 10.1111/epi.17249. Epub 2022 Apr 19. Epilepsia. 2022. PMID: 35377464 Free PMC article.

7

Population pharmacokinetics of telavancin in healthy subjects and patients with infections.

Samara E, Shaw JP, Barriere SL, Wong SL, Worboys P. Samara E, et al. Antimicrob Agents Chemother. 2012 Apr;56(4):2067-73. doi: 10.1128/AAC.05915-11. Epub 2012 Jan 17. Antimicrob Agents Chemother. 2012. PMID: 22252798 Free PMC article. Clinical Trial.

8

Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease.

Bush MA, Samara E, Whitehouse MJ, Yoshizawa C, Novicki DL, Pike M, Laham RJ, Simons M, Chronos NA. Bush MA, et al. Among authors: samara e. J Clin Pharmacol. 2001 Apr;41(4):378-85. doi: 10.1177/00912700122010230. J Clin Pharmacol. 2001. PMID: 11304894 Clinical Trial.

9

Single-dose pharmacokinetics of atrasentan, an endothelin-A receptor antagonist.

Samara E, Dutta S, Cao G, Granneman GR, Dordal MS, Padley RJ. Samara E, et al. J Clin Pharmacol. 2001 Apr;41(4):397-403. doi: 10.1177/00912700122010258. J Clin Pharmacol. 2001. PMID: 11304896 Clinical Trial.

10

Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma.

Samara E, Cao G, Locke C, Granneman GR, Dean R, Killian A. Samara E, et al. Clin Pharmacol Ther. 1997 Oct;62(4):426-35. doi: 10.1016/S0009-9236(97)90121-1. Clin Pharmacol Ther. 1997. PMID: 9357394 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters